SEC Comment Letter 0000000000-23-013202 to Tevogen Inc. (TVGN)

Tevogen Inc.
Date: Dec. 4, 2023 · CIK: 0001860871 · Accession: 0000000000-23-013202

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-41002

Date

December 4, 2023

Author

Surendra Ajjarapu

Form

UPLOAD

Company

Tevogen Inc.

Letter

United States securities and exchange commission logo December 4, 2023 Surendra Ajjarapu Chief Executive Officer Semper Paratus Acquisition Corporation 767 Third Avenue, 38th Floor New York, New York 10017 Re:Semper Paratus Acquisition Corporation Preliminary Proxy Statement on Schedule 14A Filed November 13, 2023 File No. 001-41002 Dear Surendra Ajjarapu: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andrew M. Tucker, Esq.

Show Raw Text

United States securities and exchange commission logo
December 4, 2023
Surendra Ajjarapu
Chief Executive Officer
Semper Paratus Acquisition Corporation
767 Third Avenue, 38th Floor
New York, New York 10017
Re:Semper Paratus Acquisition Corporation
Preliminary Proxy Statement on Schedule 14A
Filed November 13, 2023
File No. 001-41002
Dear Surendra Ajjarapu:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Andrew M. Tucker, Esq.

SecProbe.io